Poor dietary habits are a critical determinant of cardiovascular health and a major modifiable risk factor in the development of cardiovascular disease. 1,2 Plant-based, Mediterranean and Dietary ...

A new collaboration between JACC and the U.S. Food and Drug Administration (FDA), will give cardiovascular clinicians a voice in shaping priorities for postmarket evidence generation in cardiovascular ...

The first successful percutaneous transluminal coronary angioplasty was performed by Andreas Gruentzig, MD, in September 1977. Despite careful lesion selection, the initial equipment consisted of ...

Imagine this: the selection committee for the Nobel Prize in Physiology or Medicine is set to honor an advancement in cardiology in 2025. The question is not whether cardiology deserves it – but ...

The American Heart Association (AHA) 2024 Scientific Sessions in Chicago provided a platform for sharing the latest advancements in interventional cardiology. Here we delve into some of the most ...

Subclinical leaflet thrombosis (SLT) has raised concerns about the long-term durability and outcomes of transcatheter aortic valve replacement (TAVR). Clinical valve thrombosis (CVT) is a rare ...

The hottest research from various peer-reviewed journals – handpicked weekly by the ACC.org Editorial Board led by Kim A. Eagle, MD, MACC. BPROAD: Support For Intensive BP Control in Type 2 Diabetes ...

The ACC has issued guidance for the diagnosis and management of acute myocarditis in adult patients, delivering a streamlined decision-making framework that reflects recent advancements in clinical ...

More than 3 million individuals have taken the pledge to recognize the beginnings of a heart attack, take early action by calling 9-1-1 or activating emergency services, beginning CPR and staying with ...

ACC's advocacy priorities for 2024 focused on establishing sustainable Medicare payment practices, fostering care transformation and optimization, bolstering the clinician workforce now and for the ...

Preventing, detecting and managing cancer therapy-related cardiovascular toxicity (CTR-CVT) is a clear objective during cancer treatment. To aid in achieving this objective, a three-part Expert Panel ...

Lower extremity peripheral artery disease (PAD) is estimated to affect one of 10 Americans aged 40 years or older, with prevalence increasing with age. 1,2 Similar patterns are observed worldwide. 3 ...